Skip to main content
. 2019 Feb 4;9:1161. doi: 10.1038/s41598-018-37894-9

Figure 7.

Figure 7

Involvement of PU.1 in the expression of the human CCL22 gene. (a) mRNA levels of CCL22 and SPI1 in SPI1 siRNA (siSPI1) or control siRNA (siNega) introduced THP-1 cells. (b) Alignment of nucleotide sequences of human and mouse CCL22 genes. (c) ChIP assay was performed using either control IgG (gIgG) or anti-PU.1 Ab (α-PU.1) in THP-1 cells. The amounts of immunoprecipitated chromatin were determined by quantitative PCR targeting the −153/−76 (including cis-elements) or −2106/−2046 (cis-control) of the CCL22 promoter. Results are shown as means + S.D.s of three independent experiments.